Truist Financial’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-9,004
Closed -$403K 2844
2021
Q2
$403K Buy
9,004
+2,419
+37% +$112K ﹤0.01% 2201
2021
Q1
$331K Buy
+6,585
New +$449K ﹤0.01% 2224

Other funds holding CELL

Truist Financial's CELL Position: Q3 2021 in Review

Truist Financial sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2021, closing a stake of 9,004 shares — an estimated $403K sold.

Truist Financial first reported a position in CELL in Q1 2021 and held it in 2 quarters. The position peaked at $403K in Q2 2021. 137 funds tracked by Wall St. Rank hold CELL as of Q3 2021.

  • Truist Financial reported no remaining PhenomeX Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Truist Financial sold 9,004 PhenomeX Inc. Common Stock shares in Q3 2021, an estimated $403K.
  • Truist Financial first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Truist Financial's PhenomeX Inc. Common Stock position peaked at $403K in Q2 2021.
  • 137 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2021.

Based on Truist Financial's 13F filing for Q3 2021, filed 5 Nov 2021.